Mutational analysis of the insulinlike growth factor 1 receptor tyrosine kinase domain in non-small cell lung cancer patients

By              

Molecular and Clinical Oncology, Vol. 3, Iss. 5, 2015-01 ,pp. : 1073-1079

Science Publishers

Access to resources Recommend Favorite

A Comparison of Epidermal Growth Factor Receptor Levels and Other Prognostic Parameters in Non-small Cell Lung Cancer

By Fujino S.   Enokibori T.   Tezuka N.   Asada Y.   Inoue S.   Kato H.   Mori A.  

European Journal of Cancer, Vol. 32, Iss. 12, 1996-11 ,pp. : 2070-2074

Elsevier

Access to resources Recommend Favorite

Novel FGFR inhibitor ponatinib suppresses the growth of non-small cell lung cancer cells overexpressing FGFR1

By                  

Oncology Reports, Vol. 29, Iss. 6, 2013-01 ,pp. : 2181-2190

Spandidos Publications

Access to resources Recommend Favorite

Prognostic value of EpCAM/MUC1 mRNA-positive cells in non-small cell lung cancer patients

By Zhu Wen-Fang   Li Jian   Yu Li-Chao   Wu Yian   Tang Xin-Ping   Hu Yi-Ming   Chen Yong-Chang  

Tumor Biology, Vol. 35, Iss. 2, 2014-02 ,pp. : 1211-1219

Springer Publishing Company

Access to resources Recommend Favorite

Clinical Phase I study with an Insulin-like Growth Factor-1 Receptor Inhibitor: Experiences in patients with squamous non-small cell lung carcinoma

By Ekman Simon   Fröödin Jan-Erik   Harmenberg Johan   Bergman Antonina   Hedlund ÅÅsa   Dahg Pia   Alvfors Carina   Stååhl Birgitta   Bergströöm Stefan   Bergqvist Michael  

Acta Oncologica, Vol. 50, Iss. 3, 2011-04 ,pp. : 441-447

Informa Healthcare

Access to resources Recommend Favorite